(18F)SPA-RQ

Known as: (18F)-(2-fluoromethoxy-5-(5-trifluoromethyltetrazol-1-yl)benzyl)(2-phenylpiperidin-3-yl)amine, [18F]-labeled substance P antagonist receptor quantifier, [18F]SPA-RQ 
A radioconjugate consisting of the positron emitting radioisotope fluorine F 18 conjugated to the substance P antagonist receptor quantifier (SPA-RQ… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1991-2017
02419912017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Imdlawn Tashlhiyt Berber (ITB) is unusual due to its tolerance of non-vocalic syllabic nuclei. Rule-based and constraint-based… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
Is this relevant?
2015
2015
Much of the research in experimental pragmatics has focused on how people use the presence of weak scalar terms (like " some… (More)
Is this relevant?
2014
2014
Cerebral adenosine A2A receptors (A2ARs) are attractive therapeutic targets for the treatment of neurodegenerative and… (More)
Is this relevant?
2009
2009
BACKGROUND Positron emission tomography (PET) can localize and quantify neurokinin-1 (NK(1)) receptors in brain using the… (More)
Is this relevant?
2008
2008
The use of a boronic ester as a captor of aqueous [(18)F]-fluoride has been previously suggested as a means of labeling… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2007
2007
Substance P (SP) is a neurotransmitter and neuromodulator that mediates its effects in the brain predominantly via the neurokinin… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2007
2007
UNLABELLED (18)F-Labeled substance P antagonist-receptor quantifier ([(18)F]SPA-RQ) [2-fluoromethoxy-5-(5-trifluoromethyl… (More)
Is this relevant?
2007
2007
Receptor occupancy studies with positron emission tomography (PET) are widely used as aids in the drug development process. This… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
2004
2004
PURPOSE To develop and characterize a radiolabelled Substance-P antagonist useful for quantitation of neurokinin-1 receptors in… (More)
Is this relevant?
Review
2002
Review
2002
Substance P (SP)-neurokinin-1 (NK1) receptor pathways have been implicated in the pathophysiology of emesis and depression… (More)
Is this relevant?